Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

Cited In for PubMed (Select 16563182)

1.

Understanding susceptibility to breast cancer metastasis: the genetic approach.

Shukla A, Alsarraj J, Hunter K.

Breast Cancer Manag. 2014 Mar 1;3(2):165-172.

2.

An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease.

Faraji F, Hu Y, Wu G, Goldberger NE, Walker RC, Zhang J, Hunter KW.

Genome Res. 2014 Feb;24(2):227-40. doi: 10.1101/gr.166223.113. Epub 2013 Dec 9.

3.

BRD4 short isoform interacts with RRP1B, SIPA1 and components of the LINC complex at the inner face of the nuclear membrane.

Alsarraj J, Faraji F, Geiger TR, Mattaini KR, Williams M, Wu J, Ha NH, Merlino T, Walker RC, Bosley AD, Xiao Z, Andresson T, Esposito D, Smithers N, Lugo D, Prinjha R, Day A, Crawford NP, Ozato K, Gardner K, Hunter KW.

PLoS One. 2013 Nov 19;8(11):e80746. doi: 10.1371/journal.pone.0080746. eCollection 2013.

4.

Using a systems biology approach to understand and study the mechanisms of metastasis.

Ha NH, Hunter KW.

Wiley Interdiscip Rev Syst Biol Med. 2014 Jan-Feb;6(1):107-14. doi: 10.1002/wsbm.1237. Epub 2013 Jul 19. Review.

5.

Case-only analyses of the associations between polymorphisms in the metastasis-modifying genes BRMS1 and SIPA1 and breast tumor characteristics, lymph node metastasis, and survival.

Roberts MR, Hong CC, Edge SB, Yao S, Bshara W, Higgins MJ, Freudenheim JL, Ambrosone CB.

Breast Cancer Res Treat. 2013 Jun;139(3):873-85. doi: 10.1007/s10549-013-2601-3. Epub 2013 Jun 16.

6.

Germline genetic variation modulates tumor progression and metastasis in a mouse model of neuroendocrine prostate carcinoma.

Patel SJ, Molinolo AA, Gutkind S, Crawford NP.

PLoS One. 2013 Apr 19;8(4):e61848. doi: 10.1371/journal.pone.0061848. Print 2013.

7.

Inherited variation in miR-290 expression suppresses breast cancer progression by targeting the metastasis susceptibility gene Arid4b.

Goldberger N, Walker RC, Kim CH, Winter S, Hunter KW.

Cancer Res. 2013 Apr 15;73(8):2671-81. doi: 10.1158/0008-5472.CAN-12-3513. Epub 2013 Feb 27.

8.

Perturbation of microRNAs in rat heart during chronic doxorubicin treatment.

Vacchi-Suzzi C, Bauer Y, Berridge BR, Bongiovanni S, Gerrish K, Hamadeh HK, Letzkus M, Lyon J, Moggs J, Paules RS, Pognan F, Staedtler F, Vidgeon-Hart MP, Grenet O, Couttet P.

PLoS One. 2012;7(7):e40395. doi: 10.1371/journal.pone.0040395. Epub 2012 Jul 31.

9.

Bromodomain-Containing Protein 4: A Dynamic Regulator of Breast Cancer Metastasis through Modulation of the Extracellular Matrix.

Alsarraj J, Hunter KW.

Int J Breast Cancer. 2012;2012:670632. doi: 10.1155/2012/670632. Epub 2011 Oct 26.

10.

Differential gene expression in primary breast tumors associated with lymph node metastasis.

Ellsworth RE, Field LA, Love B, Kane JL, Hooke JA, Shriver CD.

Int J Breast Cancer. 2011;2011:142763. doi: 10.4061/2011/142763. Epub 2011 May 15.

11.

Deletion of the proline-rich region of the murine metastasis susceptibility gene Brd4 promotes epithelial-to-mesenchymal transition- and stem cell-like conversion.

Alsarraj J, Walker RC, Webster JD, Geiger TR, Crawford NP, Simpson RM, Ozato K, Hunter KW.

Cancer Res. 2011 Apr 15;71(8):3121-31. doi: 10.1158/0008-5472.CAN-10-4417. Epub 2011 Mar 9.

12.

Cancer evolution and individual susceptibility.

Pérez-Losada J, Castellanos-Martín A, Mao JH.

Integr Biol (Camb). 2011 Apr;3(4):316-28. doi: 10.1039/c0ib00094a. Epub 2011 Jan 24. Review.

13.

A systems biology approach to defining metastatic biomarkers and signaling pathways.

Goldberger NE, Hunter KW.

Wiley Interdiscip Rev Syst Biol Med. 2009 Jul-Aug;1(1):89-96. doi: 10.1002/wsbm.6. Review.

14.

Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion.

Tsygankova OM, Ma C, Tang W, Korch C, Feldman MD, Lv Y, Brose MS, Meinkoth JL.

Mol Cell Biol. 2010 Jul;30(13):3262-74. doi: 10.1128/MCB.01345-09. Epub 2010 May 3.

15.

Genetically engineered mouse models in cancer research.

Walrath JC, Hawes JJ, Van Dyke T, Reilly KM.

Adv Cancer Res. 2010;106:113-64. doi: 10.1016/S0065-230X(10)06004-5. Review.

16.

Polymorphisms in MMP9 and SIPA1 are associated with increased risk of nodal metastases in early-stage cervical cancer.

Brooks R, Kizer N, Nguyen L, Jaishuen A, Wanat K, Nugent E, Grigsby P, Allsworth JE, Rader JS.

Gynecol Oncol. 2010 Mar;116(3):539-43. doi: 10.1016/j.ygyno.2009.09.037. Epub 2009 Nov 10.

17.

Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study.

Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW.

Breast Cancer Res. 2009;11(5):R75. doi: 10.1186/bcr2412. Epub .

18.

Polymorphisms of the SIPA1 gene and sporadic breast cancer susceptibility.

Hsieh SM, Smith RA, Lintell NA, Hunter KW, Griffiths LR.

BMC Cancer. 2009 Sep 18;9:331. doi: 10.1186/1471-2407-9-331.

19.

Lessons in signaling and tumorigenesis from polyomavirus middle T antigen.

Fluck MM, Schaffhausen BS.

Microbiol Mol Biol Rev. 2009 Sep;73(3):542-63, Table of Contents. doi: 10.1128/MMBR.00009-09. Review.

20.

The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.

Crawford NP, Yang H, Mattaini KR, Hunter KW.

J Biol Chem. 2009 Oct 16;284(42):28660-73. doi: 10.1074/jbc.M109.023457. Epub 2009 Aug 26.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk